Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multinational, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study to Assess the Efficacy and Safety of Lu AA21004 in Patients With Major Depressive Disorder

NCT01255787 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT01255787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01255787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multinational, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study to Assess the Efficacy and Safety of Lu AA21004 in Patients With Major Depressive Disorder
Lead sponsor
Takeda
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2010
Completion date
April 30, 2012
Enrollment
600 (actual)
Sites
70

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major